The EBITDA margin stood at 26% in the reporting quarter versus 23.1% YoY. The results came after the close of the market hours. Shares of Gland Pharma Ltd ended at ₹1,512.15, down by ₹16.55, or 1.08%, on the BSE.
Share it
Related Article
Open an Account in less than 1 Min.
Need help? Call us
+91 888 718 7394
Services
Company
Get in touch
- +91 888 718 7394
- info@markettrade.live
- Pjazza Mifsud Bonnici, Marsascala, Malta
- 333, Pali Pathar, Khar West, Mumbai, Maharashtra 400052
Copyright © 2025 Market Trade